Fibrauretine is one of the main active ingredients from the rattan stems of Fibraurea recisa Pierre It exhibits a series of significant pharmacological effects. The present study aimed to evaluate the potential anti Alzheimer's disease (AD) effects of fibrauretine on a D-galactose/AlCl 3 -induced mouse model, and the underlying mechanisms of action were further investigated for the first time. Our results showed that pretreatment with fibrauretine significantly improved the ability of spatial shortterm working memory in the model mice during the Y-maze test, as well as the abilities of spatial learning and memory during the Morris water maze. The levels of brain tissue amyloid (Ab), P-Tau, Tau and acetylcholinesterase (AchE) were evidently increased in D-galactose/AlCl 3 -intoxicated mice, and these effects were reversed by fibrauretine. In contrast, a significant increase in the levels of the neurotransmitter acetylcholine (Ach) and choline acetyl transferase (ChAT) was observed in the fibrauretine-treated groups compared with the model group. Neuronal oxidative stress, evidenced by increased malondialdehyde (MDA) and nitric oxide (NO) levels and a decline in glutathione (GSH), catalase (CAT) and superoxide dismutase (SOD) activity, was significantly alleviated by fibrauretine pretreatment. The suppression of the neuroinflammatory response by fibrauretine was realized not only by the decrease in the levels of tumour necrosis factor-a (TNF-a) and interleukin-1b (IL-1b) in the brain tissues and by the enzyme-linked immunosorbent assay (ELISA) but also by the protein expression levels of nuclear factor-kB (NF-kB), cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS), which were measured by immunohistochemistry and western blotting. In addition, the protein expression levels of inflammatory factors interleukin-33 (IL-33) and ST2 in the brain tissues were detected by immunohistochemistry. Furthermore, the effects of western blotting demonstrated that the administration of fibrauretine significantly suppressed the protein expression levels of caspase-3, cleaved caspase-3, and Bax and increased the protein expression levels of Bcl-2, and the results of the H&E and TUNEL assay all suggested the inhibition of apoptosis in the neurons. The results clearly suggest that the underlying molecular mechanisms of action of the fibrauretine-mediated alleviation of D-galactose/AlCl 3 -induced Alzheimer's disease may involve antioxidant, anti-inflammatory, and anti-apoptotic effects.
Introduction
Alzheimer's disease (AD) is the most common type of dementia among the elderly, and AD has been prevalent with the rapidly growing global elderly population.
1 AD is a fatal neurodegenerative disease clinically characterized by progressive decline in cognitive functions such as memory loss and behavioural disturbances. 2 The neuropathologic hallmarks of AD include the presence of extracellular Ab amyloid plaque (AP) deposition and the intracellular formation of neurobrillary tangles (NFTs) in the brain, together with synaptic dysfunction characterized neurochemically by a consistent decit in cholinergic neurotransmission and a signicant loss of neuronal cells. 3 These lesions contain hyperphosphorylated tau and an excess of reactive glia in the AD brain. 4, 5 The characteristics of the ageing model for Dgalactose-induced AD mice is close to the pathological changes of clinical AD patients. A large amount of aluminium ions may induce AP deposition and formation of NFTs and is a common damage model of the cholinergic system in AD. AD model mice may be effectively induced by D-galactose combined with AlCl 3 (D-galactose/AlCl 3 ).
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The mechanisms underlying the progression of AD remain complicated. The continuous generation and abnormal accumulation of Ab in the brain causes microglial dysfunction by reducing Ab receptors, increasing the production of inam-matory mediators, 9 including TNF-a, IL-1b, NF-kB, COX-2 and iNOS. Therefore, chronic neuroinammation induced by microglia contributes to pathological progression and symptom severity, usually in the late stages of AD. Interleukin-33 (IL-33) is a new member of the IL-1 family, whose specic receptor is ST2.
10 IL-33 is constitutively expressed in the central nervous system (CNS), may induce inammatory molecule release from glial cells and plays an important role in the pathogenesis of AD.
11
Oxidative stress is an imbalance between the oxidation and reduction reactions, resulting in the production of reactive oxygen species (ROS). 12 Oxidative stress plays a very important role in the etiopathogenesis of AD. 13 Free radicals can be produced by microglial activation and generated by b-amyloid plaques. Additionally, the activation of a series of signalling protein pathways such as inammatory pathway nuclear factorkB (NF-kB) 14 can be triggered by ROS-mediated oxidative stress. Neuronal apoptosis is believed to lead to AD, and apoptosis also plays a vital role in the pathophysiology of AD. 15, 16 Apoptosis is a sophisticated biological mechanism involving a wide variety of anti-apoptosis proteins such as Bcl-2 and pro-apoptotic protein such as Bax. 17 Caspase-3, the effector caspase and nal executor of apoptosis, can cleave cytoskeletal and nuclear proteins.
18
Several studies have focused currently on natural ingredients from traditional herbal medicines to evaluate novel therapeutic drugs for the therapy of AD. Various natural ingredients, including luteolin, tetrahydropalmatine and berberine have been shown ameliorative effects on AD in vivo experiments.
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The rattan stems of Fibraurea recisa Pierre is rich in resources and mainly distributed in Yunnan and Guangxi, China, known as natural antibiotics, have traditionally been used in the treatment of gynaecological inammation and surgical infection. The rattan stems contains a kind of isoquinoline alkaloid, one of the main active ingredients, brauretine. More signicant pharmacological activities of brauretine have been discussed in the previous study, involving antitumour, 22, 23 
29
In this paper, brauretine was extracted and puried from the rattan stems of Fibraurea recisa Pierre with 60.75% extraction rate. The anti-AD effects of brauretine against D-galactose/ AlCl 3 -induced AD surveyed on a mouse model were proposed for the rst time by us. The new discovery has been authorized by the State Intellectual Property Office of China (ZL201510253034.6). In addition, the potential molecular mechanisms underlying these anti-AD effects are discussed, involving antioxidant, anti-inammatory, and anti-apoptotic activity.
Materials and methods

Preparation of brauretine
The rattan stems of Fibraurea recisa Pierre were purchased in September 2015, in Kunming of Yunnan Province, China and were identied by Prof. Lianxue Zhang. The voucher specimen was deposited at the laboratory.
The air-dried rattan stems (2 kg, 60 mesh) were extracted two times with 70% ethanol by reux extraction, each time for 2 hours. The extracts were ltered, combined and concentrated under reduced pressure to give 228.3 g of extract. The extracts were then dissolved in water and passed through a pre-treated D101 macroporous resin column (F1000 Â 100 mm), washed with 3 column volumes of water, and then eluted with 8 column volumes of 40% ethanol. The ethanol eluate was collected, the ethanol was recovered, and the eluate was then dried to yield total alkaloids (50.6 g). Total alkaloids (10 g) were dissolved in 95% ethanol, chromatographed on a basic alumina column (200 g, F880 Â 100 mm) and eluted with 95% ethanol for elution at atmospheric pressure. The alkaloids were detected by thin layer chromatography (TLC) and separated to give compound A and component I. Component I was subjected to gradient elution with methanol-water (10 : 90-50 : 50) on an ODS column (F420 Â 36 mm) to afford brauretine (24.3 g). The purity of brauretine was determined by HPLC (purity > 98%), and the structure was identied by 1 ). Fibrauretine and donepezil hydrochloride were, respectively, suspended in 0.05% carboxymethylcellulose sodium (CMC-Na) before being used. The control group mice and the model group mice received intragastrical injections with 0.05% CMC-Na. The administration operators were blind to the tested materials, and the testers were also blind to the drug treatment.
All mice were weighed every three days. Eighty days later, aer 1 h from the last administration, each group of mice was subjected to the Morris water maze and the Y-maze test and then was sacriced under general anaesthesia. Blood and sample collection was performed immediately. The brain tissue was promptly frozen in liquid nitrogen and stored at À80 C until analysis, and the brain tissue was xed in 10% neutral buffered formalin. Subsequently, serum samples were separated using a refrigerated centrifuge at 3000 Â g and stored at À20 C until used for subsequent analysis.
Y-maze test
The mice were evaluated for short-term spatial memory by a Ymaze test as previously described. 31 The Y-maze consisted of three identical arms (60 cm in length, 10 cm in width, and 15 cm in height), 120 degrees to each other. The mice were individually placed at the end of either arm and allowed to move freely through the maze within 5 minutes. Mice actively explore the maze, enter each arm in order, and remember which arm they have already entered. Spontaneous alternation is dened as the continuous entry of three arms (e.g., 1/2/3 or 1/3/2), and the spontaneous alternation rate is the ratio of the actual number of alternations to the number of possible alternations (the total number of arms minus 2) multiplied by 100%.
Morris water maze
The spatial learning and memory of mice was tested by a water maze as described in. 32 The Morris water maze consisted of a 100 cm diameter pool that was lled with water (22 C). The pool was divided into four equal quadrants, and there were visual cues in each quadrant. Mice were accepted to the hidden platform test from day 1 to day 4, with a probe trial on the h day. In the hidden platform test, the platform was placed 1 cm underwater, and each time, the mice were randomly placed in different starting positions; they were given 60 seconds to climb the hidden platform. If no platform could be found within 60 seconds, mice were guided to the platform and allowed to remain on the platform for 10 seconds. In the probe trial, the platform was removed, and mice were put into the pool to swim for 60 seconds. The memory consolidation 24 hours aer the last hidden-platform trial was assessed. The time the mouse spent in the target quadrant and the number of crossings were detected.
Assessment of biochemical parameters
The brain tissue levels of Ab, AchE, Ach, Tau, P-Tau, ChAT, GSH, TNF-a and IL-1b, as well as the serum levels of MDA, NO, CAT and SOD, were measured by ELISA. Brain tissue from each group was homogenized on ice, serum samples were segregated using a refrigerated centrifuge at 3000 Â g, then all samples were tested immediately by the ELISA kit (all purchased from R&D systems) according to the manufacturer's instructions.
H&E staining assay
Histopathological examination was performed as previously described.
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Briey, brain tissues were xed in 4%
formaldehyde solution. Aer deparaffinization with xylene, the tissues were dehydrated with different concentrations of ethanol and cut into 5 mm-thick slices. Then, all slices were stained with H&E staining solution and PAS reagents for histopathological analysis. The results were detected by optical microscope (Olympus, BX51T-PHD-J11, Japan).
TUNEL staining assay
The TUNEL staining assay was conducted to measure the extent of apoptosis in the brain aer D-galactose/AlCl 3 exposure. TUNEL evaluation was typically carried out as follows. 34 First, the brain sections (5 mm-thick) were incubated with 100 mL of 20 mg mL À1 proteinase K solution at room temperature for 15 min.
Next, the sections were incubated with 100 mL of 3% H 2 O 2 for 10 min and washed with PBS two times. Then, the TUNEL reaction mixed solution was added to the sections, and the sections were put into a humid chamber at 37 C for 1 h. Subsequently, the sections were incubated with 50 mL POD for 30 min aer washing three times with PBS. Finally, the slices were counterstained with haematoxylin. TUNEL-positive cells were visualized with an Olympus microscope (Olympus BX51, Japan).
Immunohistochemistry (IHC) analysis
IHC analysis was performed as mentioned earlier. 35 First, 5 mmthick brain sections were de-paraffinized and hydrated with aqueous alcohol solution. The sections were blocked with endogenous peroxidases for 10 min at room temperature, followed by rinsing 3 times in PBS (0.01 M, pH 7.4) for 3 min. Then, the sections were put into citrate buffer solution (0.01 M, pH 6.0) in a microwave oven (medium high temperature) for 15 min. When the temperature came to 25 C, the sections were washed three times with PBS. Next, the slides were incubated with 1% BSA for 1 h and incubated in a humidied chamber at 4 C overnight with initial antibodies involving NF-kB ( The sections were incubated with labelled streptavidin-biotin for 30 min. Finally, the sections were followed by DAB staining and counterstained with haematoxylin. The sections were dehydrated with alcohol and cleared with xylene. The immunostaining results were analysed by light microscopy (Olympus BX51, Japan).
Western blotting analysis
Western blotting analysis was carried out as mentioned previously. 36 First, brain tissue samples from each group were homogenized with lysis buffer plus 1 mM PMSF and protease inhibitor. Protein concentrations were determined using a BCA protein assay kit. The proteins (20 mg per lane) from each sample were separated with 12% SDS-PAGE and transferred to a polyvinylidene uoride (PVDF) membrane. Then, the membrane was blocked with 5% fat-free milk in tris-buffered saline (TBS) containing 0.1% Tween-20 for 2 h in a room temperature environment, aer being incubated with primary antibodies at 4 C overnight. Caspase-3, cleaved caspase-3, Bax, Bcl-2, NF-kB, COX-2 and iNOS were probed with the corresponding primary antibodies (1:1000), followed by incubation with HRP-conjugated anti-mouse anti-body or HRP-anti-rabbit antibody. Finally, the blots were inspected by the Emitter Coupled Logic (ECL) substrate with a KODAK Image Station 4000 MM (Carestream Health, Inc., New Haven, CT, USA).
Statistical analysis
All data were expressed as the means AE standard deviation (SD) of ten animals in each group and were characterized by a oneway analysis of variance (ANOVA) using SPSS17.0 (SPSS, Chicago, IL, USA). Values of p < 0.05 were considered signicant, and p < 0.01 was considered highly statistically signicant.
Results
Effects of brauretine on the abilities of learning and memory in D-galactose/AlCl 3 -treated mice
The behaviour effect of brauretine on D-galactose/AlCl 3 -induced AD mice was assessed using a Y-maze test and a Morris water maze test. The results are shown in Fig. 1 .
The results from the Y-maze test showed that a single treatment with D-galactose/AlCl 3 raised the total arm entries in the model group compared with the control group (p < 0.05), and there was no signicant difference between the model group and the brauretine-administered group (p > 0.05), and there wasn't any signicant difference between the model group and the donepezil group in the same way (Fig. 1A) . Compared with the control group, the spontaneous alternation rate of mice in the model group was signicantly decreased (p < 0.01). However, the spontaneous alternation rate was signicantly increased by donepezil (p < 0.01) and brauretine at doses of 80, 160 and 320 mg kg À1 in a dosedependent manner (p < 0.05 or p < 0.01), as shown in Fig. 1B . In the water maze experiment, the spatial learning ability of the mice was assessed by the escape latency. The mean escape latencies are shown in Fig. 1C . The results indicate that the escape latency in the model group mice was signicantly longer compared with the control group mice (p < 0.01). The escape latencies were signicantly reduced by donepezil (p < 0.01), Similarly, the escape latencies were reduced by brauretine at doses of 80, 160 and 320 mg kg À1 (p < 0.05 or p < 0.01).
Spatial memory retention is assessed by the time spent in the target quadrant and the number of crossings in the target quadrant in the exploratory experiment. Compared with the control group, the time spent in the target quadrant and the number of crossings in the target quadrant in the model group mice were both signicantly decreased (p < 0.01). In the same way, these changes in the time spent in the target quadrant and the number of passages through the target quadrant were signicantly increased by donepezil (p < 0.01) and dosedependently increased by brauretine at doses of 80, 160 and 320 mg kg À1 (p < 0.05 or p < 0.01), as shown in Fig. 1D and E.
Effects of brauretine on biochemical parameters related to AD in mice
The brain levels of Ab, AchE, Tau, P-Tau, ChAT and Ach were determined by ELISA assay. The levels of these six biochemical parameters are closely related to AD. They play very important roles in the process of AD. As shown in Fig. 2 , compared with the control group, the brain levels of Ab, AchE, Tau and P-Tau in the model group were signicantly increased (p < 0.01), and the brain levels of ChAT and Ach were signicantly decreased (p < 0.01). Ab, AchE, Tau and P-Tau levels of donepezil-administered mice were signicantly decreased (p < 0.01). And the levels of Ab, AchE, Tau and P-Tau in the brauretine-administered mice were signi-cantly decreased in a dose-dependent manner (p < 0.05 or p < 0.01). On the contrary, the levels of ChAT and Ach in the brains of donepezil were signicantly increased (p < 0.01). And ChAT, Ach levels of brauretine mice were signicantly increased in a doseindependent manner (p < 0.05 or p < 0.01). The data above indicated that brauretine has an obvious anti-AD effect.
Effects of brauretine on the oxidative stress of the brain in D-galactose/AlCl 3 -treated mice
As previously described, oxidative stress injury participated in the mechanisms of AD. 13 As indicated in Fig. 3 , D-galactose/AlCl 3 treatment caused a conspicuous reduction in glutathione (GSH) level, superoxide dismutase (SOD) activity and catalase (CAT) activity, accompanied by an increase in malondialdehyde (MDA) content and nitric oxide (NO) content, compared with the control group (p < 0.01). However, compared with the model group, the administration of brauretine reduced MDA content, NO content, and recovered antioxidant capacity, as indicated by the increase in the GSH level, SOD activity and CAT activity in a dose-independent manner (p < 0.05 or p < 0.01). So did the donepezil-treated group at dose of 1 mg kg À1 . These data suggested that brauretine alleviated oxidative damage in the serum and brain tissues by up-regulating antioxidant enzyme activity.
Effects of brauretine on histopathological changes of the brain in D-galactose/AlCl 3 -treated mice
According to the brain tissue sections in D-galactose/AlCl 3 -induced AD mice, the hippocampal neuron cell growth and shape was observed by H&E staining (Fig. 4A) . The results showed that there were fewer neurons of the hippocampus in the model group arranged heterocentrically, in which cell body, pyknotic and deeply stained nuclei shrank and the elongated axon could be found. However, these morphological changes in brauretine-treated group could be ameliorated. In the hippocampal region of brauretine 320 mg kg À1 and 160 mg kg À1 -treated groups, the neurons were arranged regularly and increased, and the improvement in the structure of the hippocampus neurons was obvious. The same result as the brauretine-treated group occurred for the donepezil-treated group.
Effects of brauretine on inammation of the brain in Dgalactose/AlCl 3 -treated mice
The previous study has conrmed that AD is related to the release of pro-inammatory cytokines, including tumour necrosis factor-a (TNF-a), interleukin-1b (IL-1b) and interleukin-33 (IL-33). [37] [38] [39] [40] The brain tissue levels of TNF-a and IL-1b were determined by the ELISA assay. As indicated in Fig. 5A and B, a single D-galactose/AlCl 3 administration resulted in obviously higher levels of TNF-a and IL-1b in the brain, compared with the control group (p < 0.01). However, these increases were reversed aer brauretine administration in a dose-dependent manner (p < 0.05 or p < 0.01). The levels of TNF-a and IL-1b in the donepezil-administered mice were also signicantly reduced (p < 0.01). The levels of IL-33 and its receptor ST2 were detected by IHC analysis. As shown in Fig. 5C and D, the positive expression area of IL-33 and ST2 levels of the model group was clearly increased, compared with the control group. But brauretine treatment resulted in dose-dependent reduction. And the administration of donepezil also reduced the levels of IL-33 and ST2 (p < 0.05). Meanwhile, to further discuss the mechanisms underlying the advantageous effects of brauretine on D-galactose/AlCl 3 -induced neuroinammation, the levels of NF-kB, COX-2 and iNOS were detected in all groups (Fig. 5E-G and 6A and H) . Compared with the control group, the positive expression area of these protein levels of the model group was clearly improved. However, these increases were attenuated by brauretine at doses of 80, 160 and 320 mg kg À1 (p < 0.05). So did the donepezil-treated group (p < 0.05).
Effects of brauretine on apoptosis of the brain in Dgalactose/AlCl 3 -treated mice
To measure the degree of apoptosis in the brains, the protein expressions of the cleaved caspase-3, anti-apoptotic factor Bcl-2 and pro-apoptotic factor Bax in all experimental groups of mice were detected. In the immunohistochemical analysis, as shown in Fig. 5H and I, the hippocampal pyramidal cells are stained in brown, and the positive cells are stained in yellow. Compared with the control group, the rates of positive expressions of Bax located in hippocampal pyramidal cytoplasm were observed to be clearly higher in the model group (p < 0.01). There is a clear reduction effect in the brauretine administration group (p < 0.05). The donepezil-treated group showed the same therapeutic effect (p < 0.05). Conversely, the positive expression of Bcl-2 in the hippocampal pyramidal cytoplasm has increased in the brauretine groups compared to the model group (p < 0.05). So did the donepezil-treated group (p < 0.05). The results of western blotting showed that D-galactose/AlCl 3 exposure signicantly increased the expression levels of cleaved caspase-3 and Bax and reduced the expression level of Bcl-2 compared with the control group (p < 0.01). However, similar to the results of immunohistochemistry, the levels of Bax, cleaved caspase-3 of the brauretine-treated groups signicantly reduced (p < 0.01). So did the donepezil-treated group (p < 0.05). (Fig. 6D-F)  (p < 0.05) .
The TUNEL assay can be used to detect DNA strand breaks that are associated with apoptosis. 41 To further conrm whether brauretine treatment could inhibit nerve cell apoptosis in Dgalactose/AlCl 3 -induced AD, the TUNEL assay was conducted (Fig. 4B) . The effect on hippocampal neuron cells was represented by the colour stained, and positive staining was in brown. The results showed that brauretine pretreatment with 80 mg kg À1 , 160 mg kg À1 and 320 mg kg À1 decreased the number of D-galactose/AlCl 3 -induced TUNEL-positive cells (p < 0.05 or p < 0.01); the same outcome occurred for the donepezil group. These results showed that brauretine showed suppressive effects against D-galactose/AlCl 3 -induced hippocampal neuron cell apoptosis.
Discussion
In the present study, a D-galactose/AlCl 3 -induced AD mice model was established to investigate the anti-AD activities of brauretine by intragastrical administration. Our results showed that brauretine signicantly enhanced the spatial short-term working memory in AD mice in the Y-maze test and the spatial learning and memory in the Morris water maze. The levels of Ab, P-Tau, Tau and AchE in brain tissue were evidently increased in the model group and were reversed by brauretine.
In contrast, a signicant increase in the levels of Ach and ChAT was observed in the brauretine-treated groups compared with the model group. The results indicated that brauretine exhibited ameliorative effects on D-galactose/AlCl 3 -induced AD in mice, in a dose-dependent manner. A great deal of evidence has implicated oxidative stress and free radical damage in the pathogenesis of AD. The damage found in AD includes advanced glycation end products, 42 nitration, 43 lipid peroxidation adduction products, 44, 45 and carbonyl-modied neurolament protein and free carbonyls. 46, 47 The antioxidant factors are represented by antioxidant enzymes such as superoxide dismutase (SOD), glutathione peroxidase (GPX), catalase or aldehyde dehydrogenase, and non-enzymatic antioxidant factors. The reaction of the reduction of free radicals is catalysed by the antioxidant enzymes, diminishing their power and hence oxidative cytotoxicity. 48 ELISA results showed that neuronal oxidative stress was induced by D-galactose/AlCl 3 in the model group, evidenced by increased malondialdehyde (MDA) and nitric oxide (NO) levels and a decline in glutathione (GSH), catalase (CAT) and superoxide dismutase (SOD) activity. All of the above abnormality was reduced by brauretine in the present work. As described above, our ndings illustrated which brauretine pretreatment recovered antioxidant ability by suppressing oxidative stress.
Numerous studies demonstrated that neuroinammation plays a critical role in the pathogenesis of AD, showing a clear involvement of several inammatory pathways.
49 NF-kB is a proinammatory transcription factor located in the cytoplasm via binding to the inhibitory IkB protein. IkB is degraded by the proteasome when it is stimulated by pathogens. Then, NF-kB is freed to translocate from the cytoplasm to the nucleus where it promotes the transcription of target genes such as TNF-a and IL-1b. At the same time, the up-regulation of iNOS and COX-2, via the NF-kB pathway, is another central mechanism in inammatory response processes. 50 Growing evidence shows that iNOS and COX-2 are clearly highly expressed at sites of inammation. Moreover, iNOS and COX-2 have synergistic effects to accelerate the inammatory response.
51 IL-33 serves as a proinammatory cytokine and an intra-cellular nuclear factor regulating transcription. IL-33 may be a specic proinammatory cytokine in the CNS.
52 IL-33 receptors containing a trans-membrane portion called ST2 are expressed in microglia and astrocytes. The glial cells respond by proliferating and releasing TNF-a, IL-1b, and NO.
40 IL-1b and TNF-a are released by IL-33 from inammatory cells.
39 Both IL-1b and TNF-a were increased in the brains of AD patients compared to control subjects. 38 Fibrauretine has traditionally been used as the anti-inammatory agent. However, its anti-inammatory mechanism is not clear. In this study, to discuss the potential molecular mechanisms and the anti-AD effects of brauretine against D-galactose/AlCl 3 -induced inammation in depth, we detected the expression levels of NF-kB, COX-2, iNOS, IL-33 and ST2. Western blotting and immunohistochemistry analysis of the results showed that brauretine pretreatment signicantly down-regulated the increase in expression levels of NF-kB, COX-2, iNOS, as well as IL-33 and ST2 aer D-galactose/AlCl 3 exposure. Moreover, ELISA results revealed that D-galactose/AlCl 3 administration increased the levels in TNF-a and IL-1b. Nevertheless, the increase in inammatory cytokine levels against Dgalactose/AlCl 3 -induced mice was dramatically suppressed by brauretine. The possible molecular mechanisms are involved in the suppression of such cytokines by brauretine. In short, the results suggested that brauretine could act as an antiinammatory agent against D-galactose/AlCl 3 -induced AD.
There is growing evidence that AD is related to apoptosis. The accumulation of Ab can induce neuronal apoptosis, which plays a vital role in AD pathogenesis. 53 The conditions inducing apoptosis that include reactive oxygen species (ROS), nitric oxide (NO), glucocorticoids and Bax overexpression are known as major factors causing the release of cytochrome c (Cyt c).
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The Bcl-2 family of proteins strictly regulates Cyt c release. 56 The family is composed of anti-apoptosis protein such as Bcl-2 and pro-apoptotic protein such as Bax. The balance between antiand pro-apoptotic proteins determines the activation of intrinsic apoptotic signals involving mitochondria. 57 When upstream caspases such as caspase-9 are activated, downstream effector caspase cleavage such as caspase-3 will be triggered, and they can cleave cytoskeletal and nuclear proteins to induce apoptosis. 58 For evaluated levels of apoptosis in brain tissues following D-galactose/AlCl 3 administration, the effects of brauretine were assessed by cleaved caspase-3, pro-apoptotic factor Bax and anti-apoptotic factor Bcl-2 in every pretreatment group. The ndings from protein detection analyses of brains markedly showed that the expression levels of Bax, caspase-3, and cleaved caspase-3 were suppressed, while the expression level of Bcl-2 was relatively activated. Additionally, the results of TUNEL staining displayed that the apoptosis rate in brain tissues was clearly reduced by brauretine when compared with the model group. In summary, the above results demonstrated that brauretine inhibited the apoptosis of brain tissues in D-galactose/AlCl 3 -induced AD mice.
In summary, AD is a complex disease involving many genetic and environmental factors. Oxidative stress has been shown to induce apoptosis by inducing cytochrome c release and activating caspase-9 and caspase-3, 59 and overproduction of free radicals would be followed by an inammatory response.
60
Among various potential causes, inammation has been suggested to be a predisposing factor in the development of neurodegenerative diseases including AD.
Nuclear factor kappa B (NF-kB) is a key inammatory mediator that regulates the expression of various genes that involved in apoptosis and inammation.
61 NF-kB is usually kept inactive in the cytoplasm through association with an endogenous inhibitor protein of the IkB family.
62 Activated NF-kB could increase the expression of other inammatory mediators such as COX-2, iNOS, IL-1b and TNF-a, which might be triggered memory impairment. 21 Interestingly, ROS accumulation in response to TNF-ais regulated in an NF-kB-dependent manner. 63 Previous study has found that inhibition of NF-kB inhibits apoptosis during the resolution of inammation in vivo and expression of genes involved in apoptosis, including the pro-apoptotic Bcl-2 homolog Bax, was modulated by NF-kB inhibitors. 64 Thus it can be seen that NF-kB plays a very important role and may be a key factor in the onset of AD. The immunohistochemistry and western blotting results from our study demonstrated that brauretine can inhibit the activation of NF-kB. Several studies have also revealed that brauretine can restrain the activation of NF-kB in other cell models or animal models.
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So brauretine from Fibraurea recisa Pierre ameliorate Dgalactose/AlCl 3 -mediated Alzheimer's disease probably by suppressing the NF-kB pathways.
Conclusion
In addition to being clinically used as an anti-inammatory drug, brauretine has been found to have a signicant anti-AD effect, the mechanism is inextricably linked to antiinammatory, anti-oxidation and anti-apoptosis.
Conflicts of interest
There are no conicts of interest to declare.
